Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reperfusion Combined with Neuroprotection for Posterior Circulation Cerebral Infarction
ChiCTR2100044882Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of edaravone and butylphthalide in brain infarction and Vertebrobasilar stroke (VBS) (2 arms), sponsored by First Affiliated Hospital of Soochow University. Primary endpoints: Interleukin 2, 4, 6, 10, 17A levels, Tumor necrosis factor alpha (TNF-α) level and 2 more. Started Mar 2021; status: recruiting.
02
Drugs
edaravonebutylphthalide
03
Conditions
brain infarctionVertebrobasilar stroke (VBS)
Beyond the preview
Go deeper on ChiCTR2100044882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044882.